Eligibility depends on many individual factors. Generally, GLP-1 use is safe and effective to treat many but not all overweight and obese patients, specifically those with a BMI of 25 or higher.

GLP-1 use is safe and effective with many pre-existing conditions with the exception of the following:

• Currently pregnant

• Currently breastfeeding

• Currently being treated for cancer

• Active eating disorder

• Active gallbladder disease

• Active substance abuse or dependency

• Type 1 diabetes

• Bariatric surgery (within the past 18 months)

• Pancreatitis within the past 6 months, or a history of pancreatiitis caused by taking a GLP-1

• Personal or family history of medullary thyroid cancer or MEN syndrome

• Personal history of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Yes, all medications are made in a State Board of Pharmacy licensed sterile compounding pharmacies, or FDA 503(b) Outsourcing Facilities. We work with pharmacies licensed in all 50 states only using the highest quality ingredients.

Actual weight lost is dependent on a number of factors. While we cannot guarantee any weight loss, many clients lose around 5% of their initial body weight. Over 12 weeks, it can be as high as 10%. This equates to a weight loss of 10–20 pounds for a 200 pound person. Everyone is different though and the most successful patients also work hard to make diet and lifestyle changes.

Yes. Semaglutide (the same ingredient in Wegovy & Ozempic) and Tirzepatide (the same ingredient in Zepbound & Mounjaro) have been shown to support weight loss and long-term weight management in multiple studies.

Side effects for GLP-1s may include nausea, vomiting, stomach pain, upset stomach, dizziness, constipation, feeling bloated, belching, gas, headaches and fatigue. Some side effects may subside after a few weeks of patient’s body getting used to the medication. EPatients may be eligible to receive prescription medication to help combat the side effects should they arise along with directions on dosage to help keep side effects to a minimum. In the most recent clinical trials, less than 5% of people discontinued GLP-1 medications because of side effects.

Our goal is to help all patients create healthy habits for long-term health. Exercise is not a requirement, but something strongly encouraged for all patients. Movement is key to good health. Many patients have anecdotally reported that exercise often becomes easier if one starts losing weight.

Our goal is to create healthy habits for long-term health. Exercise is not a requirement, but something we strongly encourage. Movement is key to good health and patients have reported that exercise becomes easier as they start losing weight.